Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 27, 1997 - Issue 10
37
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Identification of the metabolites of a new oxazolidinone MAO-A inhibitor in rat

, , , , &
Pages 1071-1089 | Published online: 22 Sep 2008

References

  • KAGAYA, T., KAHWARA, A., NAGATO, S., AKASAKA, K. and KUBOT A., 1996, E2011, a novel, selective and reversible inhibitor of monoamine oxidase type A. Journal of Pharmacology and Experimental Therapeutics, 278, 243–251.
  • NAITOH, T., H0R1E, T., NAGATO, S., KAGAYA, T., KUBOTA, A. and AKASAKA, K., 1994, Application of pharrnacokinetic studies to a novel antidepressant, E2011. Xenobiotica, 24, 819–826.
  • NAITOH, T., MISHIMA, M., KAWAGUCHI, S., MATSUI, K., ANDOH, T., KAGEI, K., KAKIKI, M., YUZURIHA, T. and HORIE, T., 1997, Absorption, distribution, metabolism and excretion of a new, 14 C-labelled oxazolidinone MAO-A inhibitor in rat and dog. Xenobiotka, 27, 1053–1070.
  • ROVEI, V., RIGAL, M., SANJUAN, M. and THIOL A., 1983, High-performance liquid chromatographic determination of cimoxatone and its O-demethyl metabolite in plasma. Journal of Chroma-tography, 277, 391–395.
  • VAJTA, S., LE MOING, J. P. and ROVEI, V., 1984, Reversed-phase high-performance liquid chromato-graphic separation of '4C-labelled toloxatone and its metabolites. Journal of Chromatography, 311, 329–337.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.